Our clinical data suggests ProLectin-M demonstrated earlier reductions in viral shedding compared with placebo with a favorable safety profile
DNA nanorobots—tiny, self-assembling machines capable of detecting diseases in blood samples within 2–4 hours
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
Subscribe To Our Newsletter & Stay Updated
